Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV

Secreted Antiviral Entry Inhibitory (SAVE) Peptides for Gene Therapy of HIV Infection

(2011) Lisa Egerer et al.   MOLECULAR THERAPY

HIV Sequence Variation Associated With env Antisense Adoptive T-cell Therapy in the hNSG Mouse Model

(2010) Rithun Mukherjee et al.   MOLECULAR THERAPY

Peaceful coexistence or clonal dominance?

(2009) D. von Laer   BLOOD

Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy

(2009) B. Cassani et al.   BLOOD

The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy

(2009) Eugenio Montini et al.   JOURNAL OF CLINICAL INVESTIGATION

The Role of TCR Specificity and Clonal Competition During Reconstruction of the Peripheral T Cell Pool

(2009) C. Leitao et al.   JOURNAL OF IMMUNOLOGY

Analysis of Lentiviral Vector Integration in HIV+ Study Subjects Receiving Autologous Infusions of Gene Modified CD4+ T Cells

(2009) Gary P Wang et al.   MOLECULAR THERAPY

Resistance of mature T cells to oncogene transformation

(2008) S. Newrzela et al.   BLOOD

T cell receptor contact to restricting MHC molecules is a prerequisite for peripheral interclonal T cell competition

(2008) Fabien Agenès et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

(2008) Elena E Perez et al.   NATURE BIOTECHNOLOGY